article thumbnail

The Changing Role of Diagnostic Labs in Personalized Oncology Care

Fierce Pharma

By Yuri Fesko, MD | Our latest white paper, delves deep into the symbiotic relationship between diagnostic labs, pharmaceutical companies, and healthcare providers in the era of precision medicine.

article thumbnail

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry

Pharma Marketing Network

For example, a pharmaceutical company could create a blog post about a new drug that it is developing. For example, a pharmaceutical company could create a white paper about a particular medical condition.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Transform patient experience with intelligent hyper-personalisation

pharmaphorum

Since 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and patient outreach, to prepare for the wave of digitisation in the healthcare industry. As part of these efforts, customer experience (CX) became a key focus area to ensure customer engagement and loyalty.

article thumbnail

How Content Marketing Drives Sales in the Pharmaceutical Industry

Pharma Marketing Network

The pharmaceutical industry is a highly regulated one, and as such, traditional marketing channels such as advertising can be limited. However, content marketing is a great way for pharmaceutical companies to reach their target audience and drive sales.

article thumbnail

Drugmakers pledge shorter launch times for drugs in EU

pharmaphorum

Pharmaceutical companies have said they will try to carve months off the time between approval and launch for new medicines in Europe, and reduce disparities between access between countries. — EFPIA (@EFPIA) April 11, 2022.

article thumbnail

Time to change the channel? The future for customer engagement models

pharmaphorum

The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceutical company engagement during the crisis. The answer was yes.

article thumbnail

It’s time get real with healthcare’s commitment to net zero

pharmaphorum

In order to incentivise innovative medicines, health technology assessment (HTA) bodies should consider evaluating the benefits that greener medicines bring to society and drive this change in the companies that are better capitalised to do so.